全文获取类型
收费全文 | 43569篇 |
免费 | 1880篇 |
国内免费 | 1005篇 |
专业分类
耳鼻咽喉 | 653篇 |
儿科学 | 932篇 |
妇产科学 | 527篇 |
基础医学 | 1654篇 |
口腔科学 | 651篇 |
临床医学 | 3609篇 |
内科学 | 5541篇 |
皮肤病学 | 661篇 |
神经病学 | 2268篇 |
特种医学 | 1017篇 |
外科学 | 5723篇 |
综合类 | 8034篇 |
预防医学 | 2826篇 |
眼科学 | 1078篇 |
药学 | 5134篇 |
53篇 | |
中国医学 | 3478篇 |
肿瘤学 | 2615篇 |
出版年
2024年 | 116篇 |
2023年 | 608篇 |
2022年 | 1421篇 |
2021年 | 1654篇 |
2020年 | 1564篇 |
2019年 | 1387篇 |
2018年 | 1424篇 |
2017年 | 1177篇 |
2016年 | 1411篇 |
2015年 | 1432篇 |
2014年 | 3466篇 |
2013年 | 3321篇 |
2012年 | 3095篇 |
2011年 | 3350篇 |
2010年 | 2843篇 |
2009年 | 2356篇 |
2008年 | 2220篇 |
2007年 | 2108篇 |
2006年 | 1737篇 |
2005年 | 1476篇 |
2004年 | 1234篇 |
2003年 | 1153篇 |
2002年 | 923篇 |
2001年 | 850篇 |
2000年 | 611篇 |
1999年 | 479篇 |
1998年 | 361篇 |
1997年 | 248篇 |
1996年 | 214篇 |
1995年 | 209篇 |
1994年 | 198篇 |
1993年 | 119篇 |
1992年 | 103篇 |
1991年 | 91篇 |
1990年 | 80篇 |
1989年 | 82篇 |
1988年 | 64篇 |
1987年 | 59篇 |
1986年 | 42篇 |
1985年 | 127篇 |
1984年 | 125篇 |
1983年 | 80篇 |
1982年 | 72篇 |
1981年 | 56篇 |
1980年 | 94篇 |
1979年 | 60篇 |
1978年 | 42篇 |
1976年 | 31篇 |
1975年 | 30篇 |
1938年 | 30篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
941.
Screening for Problem Drinking and Counseling by the Primary Care Physician-Nurse Team 总被引:5,自引:0,他引:5
Yedy Israel Oscar Hollander Martha Sanchez-Craig Suzanne Booker Virginia Miller Ronald Gingrich James G. Rankin 《Alcoholism, clinical and experimental research》1996,20(8):1443-1450
Present methods to screen for alcohol abuse are generally obtrusive and result in referral to services that deal mainly with alcoholics. These factors deter physicians from identifying alcohol abuse patients at an early stage. In the present study, 81% of all primary care physicians of a single city evaluated (i) the efficiency and the acceptability of a nonobtrusive screening method for the identification of problem drinkers and (ii) the effectiveness of brief cognitive behavioral counseling given by a nurse in a lifestyle context. Patients (n = 15,686) attending the private practices of 42 primary–care physicians were asked four alcohol–neutral trauma questions in the reception area. Physicians asked about alcohol use and alcohol-related problems only to patients with previous trauma. Problem drinkers by defined criteria were offered an appointment with a nurse who, by random assignment, gave either 3-hr of cognitive behavioral counseling over 1 year or simply advised patients to reduce their alcohol intake. The screening method identified 62–85% of expected number of problem drinkers in this population. Following the application of exclusion criteria, 105 problem drinkers were entered in the intervention part of the study. After 1 year, patients who received counseling showed significant reductions in reported alcohol consumption (-70%; p < 0.001), psychosocial problems (-85%; p < 0.001) and serum gamma glutamyl transferase (-32%h to -58%; p < 0.02). Physician visits were reduced (-34%; p < 0.02) following counseling. Patients receiving only advice showed neither reductions in psycho-social problems nor in serum gamma glutamyl transferase or physician visits, but reported a 46% reduction (p < 0.01) in alcohol consumption. Data indicate that asking patients about recent trauma is efficient and is well accepted as the first screening instrument in the identification of the problem drinker. Cost of screening per patient is under one dollar. Counseling of 3 hr given by a nurse is markedly superior (p < 0.05) to simple advice in reducing alcohol consumption, objective indicators of alcohol-related morbidity, and the frequency of physician visits. 相似文献
942.
Stefan B. Hosch M.D. Wolfram T. Knoefel M.D. Uwe Pichlmeier Ph.D. Viola Schulze M.D. Christoph Busch M.D. Karim A. Gawad M.D. Christoph E. Broelsch M.D. Dr. Jakob R. Izbicki M.D. 《Diseases of the colon and rectum》1998,41(2):159-164
PURPOSE: The present prospective, randomized clinical trial compares the outcome of surgical hemorrhoidectomy according to Parks and Milligan-Morgan in terms of hospital stay, duration of incapacity to work, symptom relief, length of morbidity, and patient convenience. METHODS: Thirty-four consecutive patients with third or fourth degree internal hemorrhoids were randomly allocated to the two groups. Before surgery, all patients were interviewed using a standard questionnaire, followed by rectal examination. All patients underwent a follow-up interview and examinations 1, 2, 4, 8, and 12 weeks after the operation. RESULTS: No serious postoperative complications were seen. Length of hospital stay (3.2 days for Parks hemorrhoidectomyvs. 4.6 days for Milligan-Morgan hemorrhoidectomy; 95 percent confidence interval, 0.2 and 2.6, respectively;P=0.02) and mean duration of incapacity to work (12.3 days for Parks hemorrhoidectomyvs. 20.2 days for Milligan-Morgan hemorrhoidectomy; 95 percent confidence interval, 5.7 and 10.2, respectively;P<0.001) differed significantly between the Milligan-Morgan and Parks patients. Until two weeks after the operation, Milligan-Morgan hemorrhoidectomy patients experienced significantly more pain. CONCLUSIONS: Our study confirms that both operations are safe, easy to perform, and lead to satisfactory results. However, the Parks procedure is the preferred option, because it minimizes patients' postoperative discomfort, is more economic, has a significantly reduced hospital stay, and has a shorter time for return to work. 相似文献
943.
新疆伊犁河谷肝棘球蚴病临床资料分析 总被引:4,自引:0,他引:4
目的 探讨新疆伊犁河谷肝棘球蚴病流行病学特点及临床诊治方法。 方法 对 1993~ 2003年伊犁河谷多家医院经手术确诊并治疗的肝棘球蚴病病例进行回顾性分析。 结果 共 2049例肝棘球蚴病患者 ,其中细粒棘球蚴病 1965例占 96% ,泡球蚴病 84例占 4%。所有病例经棘球蚴皮内过敏试验、B超、彩超、X线检查、X线断层照相术 (CT)、磁共振成像术 (MRI)、血清学免疫试验均可确诊。确诊病例经手术治疗2 034例占 99.2 %。其中 ,行肝叶切除术、肝棘球蚴外囊膜内完整切除术、肝棘球蚴囊肿外囊外切除术共 3 0 2例占 14.7% ,无术后复发及并发症。术后服药 (吡喹酮、阿苯达唑、阿苯达唑脂质体 ) 754例占 36.7% ,均有一定疗效。肝棘球蚴病流行病学特点是沿伊犁河谷流行、散布。患者均生活在农牧区 ,均有与牛、羊、狗密切接触史 ,当地各民族人群均有发病 ,女性 1 125例占 5 4%。25~49岁发病率较高为 982例占 48%。 1993-2003年发病率呈逐年下降趋势。 结论 肝棘球蚴病是新疆伊犁地区高发病、多发病 ,沿伊犁河谷流行、散布。应进一步加强病畜管理、改良手术治疗方法 ,积累临床经验。 相似文献
944.
乙肝病毒特异性转移因子治疗慢性乙型肝炎的临床研究 总被引:1,自引:0,他引:1
目的 评价乙肝病毒特异性转移因子治疗慢性乙型肝炎的临床疗效。方法 选择慢性乙型肝炎 86例 ,随机分为两组。对照组 40例 ,应用常规保肝降酶疗法 ;研究组 46例 ,在保肝降酶疗法的基础上加用乙肝病毒特异性转移因子。结果 研究组HBeAg及HBVDNA的阴转率显著高于对照组 (P <0 0 5 ) ,抗 HBe阳转率亦显著高于对照组 (P <0 0 1)。结论 乙肝病毒特异性转移因子用于治疗慢性乙型肝炎 ,可以改善患者的乙肝病毒病原学指标。 相似文献
945.
《Archives of Cardiovascular Diseases》2022,115(11):552-561
BackgroundPatients with out-of-hospital cardiac arrest (OHCA) due to acute coronary syndromes (ACS) who undergo percutaneous coronary intervention (PCI) are at high risk of bleeding and thrombosis. While predictive bleeding and stent thrombosis risk scores have been established, their performance in patients with OHCA has not been evaluated.MethodsAll consecutive patients admitted for OHCA due to ACS who underwent PCI between January 2007 and December 2019 were included. The ACTION and CRUSADE bleeding risk scores and the Dangas score for early stent thrombosis risk were calculated for each patient. A C-statistic analysis was performed to assess the performance of these scores.ResultsAmong 386 included patients, 82 patients (21.2%) experienced severe bleeding and 30 patients (7.8%) experienced stent thrombosis. The predictive performance of the ACTION and CRUSADE bleeding risk scores for major bleeding was poor, with areas under the curve (AUCs) of 0.596 and 0.548, respectively. Likewise, the predictive performance of the Dangas stent thrombosis risk score was poor (AUC 0.513). Using multivariable analysis, prolonged low-flow (odds ratio [OR] 1.03, 95% confidence interval [CI] 1.00–1.05; P = 0.025), reduced haematocrit or fibrinogen at admission (OR 0.93, 95% CI 0.88–0.98; P = 0.010 and OR 0.61; 95% CI 0.41–0.89; P = 0.012, respectively) and the use of glycoprotein IIb/IIIa inhibitors (OR 2.10, 95% CI 1.18–3.73; P = 0.011) were independent risk factors for major bleeding.ConclusionThe classic bleeding and stent thrombosis risk scores have poor performance in a population of patients with ACS complicated by OHCA. Other predictive factors might be more pertinent to determine major bleeding and stent thrombosis risks in this specific population. 相似文献
946.
Adult patients with t(8;21) acute myeloid leukemia had no superior treatment outcome to those without t(8;21): a single institution’s experience 总被引:3,自引:0,他引:3
Lee KW Choi IS Roh EY Kim DY Yun T Lee DS Yoon SS Park S Kim BK Kim NK 《Annals of hematology》2004,83(4):218-224
Clinical features and treatment outcome of 31 patients over 16 years of age with t(8;21) acute myeloid leukemia (AML) were compared with 60 patients without t(8;21). Among 31 patients with t(8;21), 15 patients were classified as AML-M2 and 11 and 5 patients as AML-M4 and M1, respectively. Of these patients, 28 patients (90.3%) achieved complete remission and 22 patients received consolidative treatment: intermediate-dose cytarabine (IDAC) 11, high-dose cytarabine (HDAC) 6, and allogeneic bone marrow transplantation (BMT) 5. When compared with patients without t(8;21), we could not demonstrate better treatment outcome for t(8;21) AML [median event-free survival (EFS) and overall survival (OS) 10.3 and 12.5 months in AML with t(8;21) vs 11.5 and 15.6 months in AML without t(8;21)]. In the t(8;21) AML group, patients who received HDAC consolidation did not show superior treatment outcome to those who received other consolidative treatment [median EFS: IDAC 11.9 months vs HDAC 9.2 months vs allogeneic BMT 38.1 months (P=NS) and median OS: IDAC 17.8 months vs HDAC 12.0 months vs allogeneic BMT 47.3 months (P=NS)]. Similar treatment outcome between patients with and without t(8;21) and non-superior treatment outcome of HDAC consolidative chemotherapy in the t(8;21) AML group in our study is contradictory to previous reports.These two authors equally contributed to this study: K.-W. Lee and I. S. ChoiSupported by a grant CRI-01-07 from the Cancer Research Institute, Seoul National University College of Medicine, and a grant 05-2001-002 from the S.N.U.H. Research Fund 相似文献
947.
Acute Myeloid Leukemia (AML) is a disorder affecting primarily elderly individuals and poses significant treatment challenges. Much has been learned about the underlying immunologic, cytogenetic and molecular features of AML in recent years, and many features have been identified that portend a poor prognosis for elderly patients with newly diagnosed AML. Despite this, treatment outcomes for elderly patients remain poor for both newly diagnosed and relapsed disease. While conventional treatment approaches may be appropriate for some elderly patients, the vast majority do not tolerate intensive chemotherapy well, thus alternative strategies have been investigated. Here we review both conventional and novel treatment approaches for elderly patients with AML, including agents in early clinical trials. Treatment options have been divided into several discussions, including conventional treatments, agents complementary to conventional treatments, alternatives to conventional induction therapies, post-induction treatment, and relapsed disease. Current and developing research focuses upon identifying subgroups of patients that benefit more from specific chemotherapeutic agents. Treating elderly patients with AML requires an organized, multidisciplinary approach, taking into account individual patient characteristics, preferences, and comorbidities when formulating treatment plans. 相似文献
948.
Diltiazem reverses tissue Doppler velocity abnormalities in pre-clinical hypertrophic cardiomyopathy
McTaggart DR 《Heart, lung & circulation》2004,13(1):39-40
BACKGROUND: Abnormalities in systolic and diastolic function shown by tissue Doppler imaging have been shown to be present in patients with hypertrophic cardiomyopathy who do not yet show clinical or echocardiographic evidence of the disease. These become more marked as left ventricular hypertrophy develops. We attempted to show that these abnormalities could be reversed by treatment with diltiazem. METHODS AND RESULTS: Six adults, who were carriers of a mutation involving the cardiac myosin binding, protein-C gene and who did not show clinical electrocardiographic or echocardiographic evidence of the disease were given a dose of 240mg of diltiazem daily. Tissue Doppler peak systolic and early diastolic velocities at the lateral mitral annulus were examined before treatment and at a mean of 8 weeks after starting treatment. Improvement in both parameters occurred with early diastolic velocities returning to normal and most systolic velocities also becoming normal. CONCLUSION: Diltiazem may have a role in helping to prevent abnormalities of function and perhaps the development of left ventricular hypertrophy in patients with pre-clinical hypertrophic cardiomyopathy. 相似文献
949.
Rong‐Kuo Lyu Wei‐Hung Chen Sung‐Tsang Hsieh 《Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy》2002,6(2):163-166
Abstract: Previous studies have shown that both plasma exchange (PE) and double filtration plasmapheresis (DFPP) are effective treatments in Guillain‐Barré syndrome (GBS). Whether PE and DFPP have similar effects in GBS is not clear. This report compares the therapeutic effectiveness of PE and DFPP in GBS patients treated in 3 major hospitals in northern Taiwan. A total of 102 patients were included in this survey, including 39 with PE (hereafter PE group) and 63 with DFPP (hereafter DFPP group). Both groups showed significant improvement of disability scores after treatment. However, time to onset of effect was shorter (5.6 ± 3.5 versus 7 ± 3.4 days, p < 0.05), and changes of disability scores were more prominent (1.3 ± 0.8 versus 0.8 ± 0.8, p < 0.05) in the PE group than the DFPP group. Mortality and outcome after 6 months were not different between the 2 groups. In conclusion, both PE and DFPP are effective treatments in GBS. PE was superior to DFPP in short‐term effectiveness. The long‐term effectiveness was not different. 相似文献
950.
Y. L. Kwong K. F. Wong R. H. S. Liang Y. C. Chu L. C. Chan T. K. Chan 《Annals of hematology》1996,72(3):137-140
Pure red cell aplasia (PRCA) is a rare hematological disease characterized by selective marrow erythroid aplasia. We report
the clinical features and treatment results of 16 Chinese patients with PRCA. Nine (56%) cases were not associated with any
underlying disorders and were considered idiopathic, while seven patients (44%) had associated diseases, three involving the
thymus, two with T large granular lymphocyte leukemia (T-LGLL), and one each with Stevens-Johnson syndrome and acute hepatitis
A. Conventional-dose corticosteroid therapy resulted in complete remission in three of 13 patients. Cyclosporin A was used
in six patients. There were three complete and one partial remissions. High-dose methylprednisolone was ineffective in four
patients who failed conventional-dose corticosteroids but achieved complete remission in one patient with thymoma who did
not respond to thymectomy. Antithymocyte globulin was used in four patients, resulting in partial remission in only one patient
with concomitant T-LGLL. Intravenous gamma globulin and danazol were ineffective in three patients. Thymectomy was performed
in two patients, with one patient remitting. This is the largest series of PRCA reported in an oriental population. Our results
indicate that treatment of PRCA may still be problematic and better therapeutic strategy will have to be defined.
Received: 11 September 1995 / Accepted: 1 January 1996 相似文献